Current statistical issues in clinical cancer research.
作者信息
Altman D G, Machin D
出版信息
Br J Cancer. 1993 Sep;68(3):455-6. doi: 10.1038/bjc.1993.368.
Abstract
摘要
相似文献
1
Current statistical issues in clinical cancer research.
Br J Cancer. 1993 Sep;68(3):455-6. doi: 10.1038/bjc.1993.368.
2
Key statistical concepts in cancer research.
Clin Adv Hematol Oncol. 2015 Mar;13(3):180-5.
3
Canada tops cancer research impact list.
Nat Med. 2001 Dec;7(12):1261. doi: 10.1038/nm1201-1261b.
4
Representation of women as authors of collaborative cancer clinical trials.
JAMA Intern Med. 2014 May;174(5):806-8. doi: 10.1001/jamainternmed.2014.250.
5
N-of-1 trials in oncology.
Lancet Oncol. 2015 Aug;16(8):885-6. doi: 10.1016/S1470-2045(15)00062-5.
6
Central statistical monitoring of investigator-led clinical trials in oncology.
Int J Clin Oncol. 2020 Jul;25(7):1207-1214. doi: 10.1007/s10147-020-01726-6. Epub 2020 Jun 23.
7
Ethical issues in oncology biostatistics.
Stat Methods Med Res. 2002 Oct;11(5):429-48. doi: 10.1191/0962280202sm301ra.
8
Increasing accrual in cancer clinical trials with a focus on minority enrollment: The William Beaumont Hospital Community Clinical Oncology Program Experience.
Cancer. 2011 Oct 15;117(20):4764-71. doi: 10.1002/cncr.26094. Epub 2011 Mar 31.
9
Nine-year change in statistical design, profile, and success rates of Phase II oncology trials.
J Biopharm Stat. 2016;26(1):141-9. doi: 10.1080/10543406.2015.1092030.
10
A proposed modification to Hy's law and Edish criteria in oncology clinical trials using aggregated historical data.
Pharmacoepidemiol Drug Saf. 2013 Jun;22(6):571-8. doi: 10.1002/pds.3405.
引用本文的文献
1
Confidence intervals can be helpful.
Br J Cancer. 1994 Oct;70(4):778. doi: 10.1038/bjc.1994.396.
本文引用的文献
1
A method of estimating comparative rates from clinical data; applications to cancer of the lung, breast, and cervix.
J Natl Cancer Inst. 1951 Jun;11(6):1269-75.
2
Statistical aspects of the analysis of data from retrospective studies of disease.
J Natl Cancer Inst. 1959 Apr;22(4):719-48.
3
Statistics in medical journals.
Stat Med. 1982 Jan-Mar;1(1):59-71. doi: 10.1002/sim.4780010109.
4
Statistical guidelines for contributors to medical journals.
Br Med J (Clin Res Ed). 1983 May 7;286(6376):1489-93. doi: 10.1136/bmj.286.6376.1489.
5
Methodologic guidelines for reports of clinical trials.
Cancer Treat Rep. 1985 Jan;69(1):1-3.
6
Guidelines for statistical reporting in articles for medical journals. Amplifications and explanations.
Ann Intern Med. 1988 Feb;108(2):266-73. doi: 10.7326/0003-4819-108-2-266.
7
Use of check lists in assessing the statistical content of medical studies.
Br Med J (Clin Res Ed). 1986 Mar 22;292(6523):810-2. doi: 10.1136/bmj.292.6523.810.
8
Survival analysis 1982-1991: the second decade of the proportional hazards regression model.
Stat Med. 1991 Dec;10(12):1931-41. doi: 10.1002/sim.4780101208.
9
Statistics in medical journals: developments in the 1980s.
Stat Med. 1991 Dec;10(12):1897-913. doi: 10.1002/sim.4780101206.
10
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.
Br J Cancer. 1977 Jan;35(1):1-39. doi: 10.1038/bjc.1977.1.
Zotero 插件